Salomon & Ludwin’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.78K Sell
752
-977
-57% -$7.35K ﹤0.01% 1771
2025
Q4
$12.9K Sell
1,729
-172
-9% -$1.36K ﹤0.01% 1265
2025
Q3
$20.9K Buy
1,901
+1,799
+1,764% +$17.7K ﹤0.01% 780
2025
Q2
$1.03K Hold
102
﹤0.01% 739
2025
Q1
$1.52K Hold
102
﹤0.01% 607
2024
Q4
$1.52K Sell
102
-7
-6% -$114 ﹤0.01% 621
2024
Q3
$2.08K Sell
109
-32
-23% -$663 ﹤0.01% 609
2024
Q2
$2.92K Sell
141
-166
-54% -$3.3K ﹤0.01% 575
2024
Q1
$5.77K Sell
307
-213
-41% -$3.65K ﹤0.01% 616
2023
Q4
$9.03K Hold
520
﹤0.01% 508
2023
Q3
$9.03K Buy
+520
New +$10.8K ﹤0.01% 506

Other funds holding OGN

Salomon & Ludwin's OGN Position: Q1 2026 in Review

Salomon & Ludwin reduced its Organon & Co (OGN) stake by 57% in Q1 2026, selling an estimated $7.35K and leaving 752 shares worth $4.78K. The position accounts for ﹤0.01% of the portfolio, ranked #1771.

Salomon & Ludwin first reported a position in OGN in Q3 2023 and has held it in 11 quarters since. The position peaked at $20.9K in Q3 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Salomon & Ludwin held 752 shares of Organon & Co worth $4.78K as of Q1 2026.
  • Salomon & Ludwin sold 977 Organon & Co shares in Q1 2026, an estimated $7.35K.
  • Organon & Co made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #1771 holding.
  • Salomon & Ludwin first reported a position in Organon & Co in Q3 2023 and has held it in 11 quarters since.
  • Salomon & Ludwin's Organon & Co position peaked at $20.9K in Q3 2025.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.